Use access key #2 to skip to page content.
$76.88 4.09 (5.62%)
7/8/2008 4:00 PM

Genzyme Corp (GENZ)

CAPS Rating:
*****

A biotechnology company dedicated to making an impact on the lives of people with serious diseases. Its product and service portfolio is focused on rare disorders, renal diseases, orthopaedics, organ transplant, and diagnostic and predictive testing.

View All Commentary (GENZ)

Recs

2

Avatar tkies60537 (66.92) Submitted: 12/08/06 7:35 PM : Outperform Start Price: $61.74 GENZ Score: 34.58

Genzyme makes mad money in diseases. The company's product portfolio focuses on rare genetic disorders as well as organ transplant, osteoarthritis, and renal disease. One of its main products, Cerezyme, is a leading (and pricey) treatment for Gaucher's disease, a rare enzyme-deficiency condition. Genzyme also is involved in drug development and genetic testing and other services.

Report this Post Replies: 1 | Reply

Avatar extremeinvesting (98.02) Submitted: 1/12/07 2:24 AM

Recs: 0 | Rec This

Yes, this "extreme performance stock" is postured well to take advantage of its niche.

Report this Post Reply

Featured Broker Partners